# Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection

> **NCT04264130** · PHASE2 · COMPLETED · sponsor: **Centre de Recherche Médicale de Lambaréné** · enrollment: 54 (actual)

## Conditions studied

- Schistosomiasis Haematobia

## Interventions

- **DRUG:** Artesunate-Pyronaridine
- **DRUG:** Artemether-Lumefantrine
- **DRUG:** Artefenomel-Ferroquine

## Key facts

- **NCT ID:** NCT04264130
- **Lead sponsor:** Centre de Recherche Médicale de Lambaréné
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-31
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264130, "Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04264130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*